Carmell Therapeutics Corp. Securities Investigation
Are you concerned about your investment in Carmell Therapeutics Corp.? If so, the securities attorneys at The White Law Group may be able to help you recoup your losses by filing a FINRA Arbitration claim against the brokerage firm that sold you the investment.
Carmell Therapeutics Corp., a privately-owned biotechnology company, is reportedly focused on the development and commercialization of innovative Plasma-based Bioactive Materials (PBMs), according to its website. The company reportedly filed a Form D to raise capital from investors in 2018, according to SEC filings.
The Risks of Investing in Reg D Private Placements
Private placements are a means for smaller companies to raise capital through the sale of equity or debt securities without having to register their securities with the SEC. These investments are often riskier and more complicated than traditional investments, and are only suitable for high net worth, sophisticated investors.
Broker dealers are required to perform adequate due diligence on any investment they recommend and to ensure that all recommendations are suitable for the investor. Recommendations should be in line with the investor’s age, risk tolerance, net worth, and investment experience.
Despite the risks of investing in this type of alternative investments, brokerage firms continue to push this type of investment because of the high commissions associated with their sale and creation.
The White Law Group is investigating the liability that FINRA registered brokerage firms may have for improperly selling alternative investment products to its clients.
If you are concerned about your investment in Carmell Therapeutics Corp. or another private placement investment and would like to speak with a securities attorney about your options, please call The White Law Group at 888-637-5510 for a free consultation.
The White Law Group is a national securities fraud, securities arbitration, and investor protection law firm with offices in Chicago, Illinois.
For more information on The White Law Group and its representation of investors in FINRA arbitration claims, visit?https://www.whitesecuritieslaw.com.
Tags: Carmell Therapeutics Corp. complaints, Carmell Therapeutics Corp. investigation, Carmell Therapeutics Corp. investment, Carmell Therapeutics Corp. lawsuit, Carmell Therapeutics Corp. review, Carmell Therapeutics Corp. value Last modified: March 24, 2021